Postgrad Med J

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Postgraduate Medical Journal 2006;82:16-23; doi:10.1136/pgmj.2005.034199
Copyright © 2006 The Fellowship of Postgraduate Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellery, S
Right arrow Articles by Frenneaux, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellery, S
Right arrow Articles by Frenneaux, M

REVIEW

Role of resynchronisation therapy and implantable cardioverter defibrillators in heart failure

S Ellery , L Williams , M Frenneaux

Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK

Correspondence to:
Correspondence to:
Dr L Williams
Department of Cardiovascular Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; L.K.Williams{at}bham.ac.uk

The worldwide prevalence of heart failure is increasing in part because of an aging population. In the developed world, heart failure affects 1%–2% of the general population, accounting for 5% of adult hospital admissions. There is now convincing evidence supporting the beneficial effects of cardiac resynchronisation therapy for the treatment of heart failure. Numerous observational studies, as well as a series of randomised controlled trials, have shown the safety, efficacy, and long term benefits for patients with chronic systolic heart failure who have broad QRS complexes and refractory symptoms despite optimal medical therapy. These studies have consistently found statistically significant improvements in quality of life, New York Heart Association functional class, exercise tolerance, and left ventricular reverse remodelling. Recent evidence suggests that the benefit may at least in part be because of a reduction in mechanical dysynchrony.


Abbreviations: NYHA, New York Heart Association; LBBB, left bundle branch block; CRT, cardiac resynchronisation therapy; ICD, implantable cardioverter defibrillator; TDI, tissue Doppler imaging; TSI, tissue synchronisation imaging; LYG, life year gained

Keywords: heart failure; cardiac resynchronisation therapy; implantable cardioverter defibrillator







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 The Fellowship of Postgraduate Medicine